Nonanaplastic pleomorphic xanthoastrocytoma with meningeal dissemination presenting with bilateral visual loss

Journal of Neuroimaging

Volumn 24, Issue 5, 2014, Pages 533-535

  Delgado Alvarado, Manuel ^a   Gómez Román, Javier ^a   Sánchez Salmón, Elena ^a   Rodríguez Rodríguez, Eloy ^a   Polo, José M ^a   García Castaño, Almudena ^a   Berciano, José ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Idiopathic intracranial hypertension; Magnetic resonance imaging; Meningeal neoplasm; Pleomorphic xanthoastrocytoma; Temozolamide

Indexed keywords

ACETAZOLAMIDE; DEXAMETHASONE; GLIAL FIBRILLARY ACIDIC PROTEIN; TEMOZOLOMIDE; DACARBAZINE;

ADULT; ARTICLE; BILATERAL VISUAL LOSS; BLINDNESS; BRAIN BIOPSY; BRAIN DAMAGE; BRAIN METASTASIS; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CANCER GROWTH; CASE REPORT; CELL PROLIFERATION; CENTRAL SULCUS; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DETERIORATION; DRUG TREATMENT FAILURE; HUMAN; HUMAN TISSUE; IDIOPATHIC INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MALE; MENINGEAL DISSEMINATION; NEUROIMAGING; NONANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; PLEOMORPHIC XANTHOASTROCYTOMA; PROTEIN CONTENT; VISUAL ACUITY; VISUAL IMPAIRMENT; ANALOGS AND DERIVATIVES; ASTROCYTOMA; BRAIN NEOPLASMS; COMPLICATION; HEADACHE; MULTIMODALITY CANCER THERAPY; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ASTROCYTOMA; BLINDNESS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; HEADACHE; HUMANS; MALE; TREATMENT OUTCOME; VENTRICULOPERITONEAL SHUNT;

EID: 84908544982     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/jon.12031     Document Type: Article

References (11)

1. Giannini C, Scheithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999;85:2033-2045.
2. Crespo-Rodriguez AM, Smirniotopoulos JG, Rushing EJ. MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology 2007;49:307-315.
3. Fouladi M, Jenkins J, Burger P, et al. Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro Oncol 2001;3:184-192.
4. Lubansu A, Rorive S, David P, et al. Cerebral anaplastic pleomorphic xanthoastrocytoma with meningeal dissemination at first presentation. Childs Nerv Syst 2004;20:119-122.
5. McLean CA, Jellinek DA, Gonzales MF. Diffuse leptomeningeal spread of pleomorphic xanthoastrocytoma. J Clin Neurosci 2008;5:230-233.
6. Koga T, Morita A, Maruyama K, et al. Long-term control of disseminated pleomorphic xanthoastrocytoma with anaplastic features by means of stereotactic irradiation. Neuro Oncol 2009;11:446-451.
7. Okazaki T, Kageji T, Matsuzaki K, et al. Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis-a pediatric case report and review of the literature. J Neurooncol 2009;94:431-437.
8. Ball AK, Clarke CE. Idiopathic intracranial hypertension. Lancet Neurol 2006;5:433-442.
9. Ashworth B, Gordon A. Leptomeningeal gliomatosis. J Neurol Neurosurg Psychiatry 1994;57:471-473.
10. Pahapill PA, Ramsay DA, Del Maestro RF. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. Neurosurgery 1996;38:822-828.
11. Gururangan S, Fisher MJ, Allen JC, et al. Temozolomide in children with progressive low-grade glioma. Neuro Oncol 2007;9:161-168.